Dongwha Pharm.Co.Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.044x

Dongwha Pharm.Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) has a cash flow conversion efficiency ratio of 0.044x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩18.34 Billion ≈ $12.43 Million USD) by net assets (₩415.47 Billion ≈ $281.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Dongwha Pharm.Co.Ltd (2011–2025)

Cash flow conversion efficiency of Dongwha Pharm.Co.Ltd from 2011 to 2025. This chart illustrates how Dongwha Pharm.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Dongwha Pharm.Co.Ltd (000020) share price today for real-time trading data and today's change.

Dongwha Pharm.Co.Ltd Cash Flow Conversion Ratio Explained

Dongwha Pharm.Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Dongwha Pharm.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dongwha Pharm.Co.Ltd ranked by their cash flow conversion efficiency. Also see 000020 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Bixolon Co. Ltd KQ:093190	0.033x
Precision Camshafts Limited NSE:PRECAM	0.077x
LENZ Therapeutics Inc NASDAQ:LENZ	-0.177x
Tamil Nadu Newsprint & Papers Limited NSE:TNPL	-0.022x
Rockridge Resources Ltd V:ROCK	0.028x
AKA Brands Holding Corp NYSE:AKA	-0.041x
Betr Entertainment Ltd AU:BBT	-0.135x
Swelect Energy Systems Limited NSE:SWELECTES	0.069x

Annual Cash Flow Conversion Efficiency for Dongwha Pharm.Co.Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Dongwha Pharm.Co.Ltd from 2011 to 2025. Review how much free cash does Dongwha Pharm.Co.Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩401.44 Billion ≈ $272.05 Million	₩15.70 Billion ≈ $10.64 Million	0.039x	+492.38%
2024-12-31	₩401.68 Billion ≈ $272.21 Million	₩-4.00 Billion ≈ $-2.71 Million	-0.010x	-113.91%
2023-12-31	₩407.06 Billion ≈ $275.86 Million	₩29.17 Billion ≈ $19.77 Million	0.072x	-7.15%
2022-12-31	₩378.67 Billion ≈ $256.62 Million	₩29.22 Billion ≈ $19.80 Million	0.077x	-22.87%
2021-12-31	₩360.13 Billion ≈ $244.06 Million	₩36.03 Billion ≈ $24.42 Million	0.100x	-34.35%
2020-12-31	₩342.68 Billion ≈ $232.23 Million	₩52.23 Billion ≈ $35.39 Million	0.152x	+245.17%
2019-12-31	₩300.87 Billion ≈ $203.90 Million	₩13.28 Billion ≈ $9.00 Million	0.044x	+401.18%
2018-12-31	₩297.40 Billion ≈ $201.54 Million	₩-4.36 Billion ≈ $-2.95 Million	-0.015x	+73.65%
2017-12-31	₩296.94 Billion ≈ $201.24 Million	₩-16.52 Billion ≈ $-11.20 Million	-0.056x	-155.22%
2016-12-31	₩252.93 Billion ≈ $171.40 Million	₩25.48 Billion ≈ $17.27 Million	0.101x	+16.90%
2015-12-31	₩230.12 Billion ≈ $155.95 Million	₩19.83 Billion ≈ $13.44 Million	0.086x	+46.50%
2014-12-31	₩229.73 Billion ≈ $155.68 Million	₩13.51 Billion ≈ $9.16 Million	0.059x	+62.92%
2013-12-31	₩227.23 Billion ≈ $153.99 Million	₩8.21 Billion ≈ $5.56 Million	0.036x	-67.51%
2012-12-31	₩226.99 Billion ≈ $153.83 Million	₩25.23 Billion ≈ $17.10 Million	0.111x	-44.82%
2011-12-31	₩229.62 Billion ≈ $155.61 Million	₩46.24 Billion ≈ $31.34 Million	0.201x	--

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$95.80 Million

₩141.36 Billion KRW

Market Cap Rank

#19168 Global

#927 in Korea

Share Price

₩5100.00

Change (1 day)

-1.16%

52-Week Range

₩4550.00 - ₩6670.00

All Time High

₩28554.43